Cite
A novel mechanism for oral controlled release of drugs by continuous degradation of a phospholipid prodrug along the intestine: in-vivo and in-vitro evaluation of an indomethacin-lecithin conjugate
MLA
Amnon Hoffman, et al. “A Novel Mechanism for Oral Controlled Release of Drugs by Continuous Degradation of a Phospholipid Prodrug along the Intestine: In-Vivo and in-Vitro Evaluation of an Indomethacin-Lecithin Conjugate.” Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 119, no. 1, June 2006. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....35df96c8c3d81e9b7e8a9ba71635a4e6&authtype=sso&custid=ns315887.
APA
Amnon Hoffman, Eran Dvir, Arik Dahan, Anat Elmann, & Revital Duvdevani. (2006). A novel mechanism for oral controlled release of drugs by continuous degradation of a phospholipid prodrug along the intestine: in-vivo and in-vitro evaluation of an indomethacin-lecithin conjugate. Journal of Controlled Release : Official Journal of the Controlled Release Society, 119(1).
Chicago
Amnon Hoffman, Eran Dvir, Arik Dahan, Anat Elmann, and Revital Duvdevani. 2006. “A Novel Mechanism for Oral Controlled Release of Drugs by Continuous Degradation of a Phospholipid Prodrug along the Intestine: In-Vivo and in-Vitro Evaluation of an Indomethacin-Lecithin Conjugate.” Journal of Controlled Release : Official Journal of the Controlled Release Society 119 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....35df96c8c3d81e9b7e8a9ba71635a4e6&authtype=sso&custid=ns315887.